-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Low protein solubility is a problem in many areas of protein science. Although chemical methods have been developed to solubilizeproteins these are not always effective and add to the cost of producing the protein. One way of overcoming these difficultiesis to evolve the protein to be more soluble. A major hurdle in this process is the ability to select mutant proteins withenhanced solubility from a large library of randomly mutated proteins. In this article, we describe such a method. The methodrelies on the fact that increasing the expression of dihydrofolate reductase (DHFR) makes
Escherichia coli
resistant to Trimethoprim (TMP). Proteins fused to DHFR will produce chimeras with altered levels of resistance to TMP. Thisvariation in TMP resistance can be used to identify mutant proteins with enhanced solubility.